HN2008000964A - Enmascaramiento del sabor de polvos - Google Patents

Enmascaramiento del sabor de polvos

Info

Publication number
HN2008000964A
HN2008000964A HN2008000964A HN2008000964A HN2008000964A HN 2008000964 A HN2008000964 A HN 2008000964A HN 2008000964 A HN2008000964 A HN 2008000964A HN 2008000964 A HN2008000964 A HN 2008000964A HN 2008000964 A HN2008000964 A HN 2008000964A
Authority
HN
Honduras
Prior art keywords
flavor mask
dust
dust flavor
mask
administration
Prior art date
Application number
HN2008000964A
Other languages
English (en)
Inventor
Rainer Bellinghausen
Daniel Rudhardt
Frank Ridder
Martin Steinbeck
Jesko Zank
Martin Weiss
Olaf Behrend
Stiphout Udo Van
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HN2008000964A publication Critical patent/HN2008000964A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS POLVOS DE SABOR ENMASCARADO PARA INHALACION O ADMINISTRACION ORAL, A UN PROCEDIMIENTO SENCILLO PARA SU PREPARACION Y A S USO PARA LA ADMINISTRACION DE SUSTANCIAS BIOLOGICAMENTE ACTIVAS
HN2008000964A 2005-12-24 2008-06-24 Enmascaramiento del sabor de polvos HN2008000964A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005062270A DE102005062270A1 (de) 2005-12-24 2005-12-24 Geschmacksmaskierung von Pulvern

Publications (1)

Publication Number Publication Date
HN2008000964A true HN2008000964A (es) 2013-03-11

Family

ID=38042692

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008000964A HN2008000964A (es) 2005-12-24 2008-06-24 Enmascaramiento del sabor de polvos

Country Status (24)

Country Link
US (1) US20090269411A1 (es)
EP (1) EP1968555A2 (es)
JP (2) JP5275039B2 (es)
KR (2) KR101245627B1 (es)
CN (1) CN101346133A (es)
AU (1) AU2006331009B2 (es)
BR (1) BRPI0620618A2 (es)
CA (1) CA2634481A1 (es)
CR (1) CR10112A (es)
CU (1) CU23877B1 (es)
DE (1) DE102005062270A1 (es)
EC (1) ECSP088577A (es)
GT (1) GT200800126A (es)
HN (1) HN2008000964A (es)
IL (1) IL192085A0 (es)
MA (1) MA30072B1 (es)
MY (1) MY149601A (es)
NZ (1) NZ569279A (es)
RU (1) RU2440103C2 (es)
SV (1) SV2009002971A (es)
TN (1) TNSN08284A1 (es)
UA (1) UA93072C2 (es)
WO (1) WO2007073911A2 (es)
ZA (1) ZA200805498B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
MX2010008940A (es) * 2008-02-13 2010-10-05 Bayer Schering Pharma Ag Sistemas de administracion de drogas que contienen estradiol.
US20110052699A1 (en) * 2008-02-13 2011-03-03 Adrian Funke Drug delivery system with stabilising effect
NZ593217A (en) * 2008-12-05 2013-05-31 Bayer Ip Gmbh Extrudate having spicular active substances
EP3130396B1 (en) 2009-03-27 2021-03-17 Bend Research, Inc. Spray-drying process
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
CA2771358A1 (en) 2009-08-19 2011-02-24 Sascha General Drug delivery systems (wafer) for pediatric use
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
MX364560B (es) 2010-09-20 2019-05-02 Spi Pharma Inc Star Proceso de microencapsulacion y producto.
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
CA2962719A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
NZ507951A (en) * 1998-04-09 2002-12-20 Eurand Internat S Wettable microcapsules having hydrophobic polymer coated cores
FR2811913B1 (fr) * 2000-07-19 2003-09-19 Separex Sa Procede d'encapsulation sous forme de micro-capsules de fines particules solides
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.

Also Published As

Publication number Publication date
ECSP088577A (es) 2008-07-30
CN101346133A (zh) 2009-01-14
AU2006331009A1 (en) 2007-07-05
RU2440103C2 (ru) 2012-01-20
GT200800126A (es) 2010-06-25
ZA200805498B (en) 2009-11-25
KR20120006085A (ko) 2012-01-17
MA30072B1 (fr) 2008-12-01
JP5275039B2 (ja) 2013-08-28
TNSN08284A1 (en) 2009-10-30
KR101245627B1 (ko) 2013-03-20
SV2009002971A (es) 2009-04-28
KR20080081021A (ko) 2008-09-05
CA2634481A1 (en) 2007-07-05
CU20080124A7 (es) 2010-08-30
CU23877B1 (es) 2013-04-19
IL192085A0 (en) 2008-12-29
JP2009521419A (ja) 2009-06-04
DE102005062270A1 (de) 2007-06-28
CR10112A (es) 2009-01-07
UA93072C2 (ru) 2011-01-10
AU2006331009B2 (en) 2012-10-04
EP1968555A2 (de) 2008-09-17
US20090269411A1 (en) 2009-10-29
MY149601A (en) 2013-09-13
RU2008130171A (ru) 2010-01-27
NZ569279A (en) 2011-06-30
WO2007073911A2 (de) 2007-07-05
BRPI0620618A2 (pt) 2011-11-16
JP2013144695A (ja) 2013-07-25
WO2007073911A3 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
HN2008000964A (es) Enmascaramiento del sabor de polvos
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BRPI0710508B8 (pt) composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído
ITMI20051999A1 (it) Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
WO2007016563A3 (en) Alcohol resistant pharmaceutical formulations
WO2007092620A3 (en) Stable formulations, and methods of their preparation and use
ATE556704T1 (de) Pulverinhalator-formulierungen
UA105210C2 (ru) Противораковая вакцина и ее применение
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
DK2104490T3 (da) Mikroniserede partikler af aktive bestanddele med lavdosis-styrke til pulverformuleringer til inhalation
EA201070129A1 (ru) Фармацевтический сухой порошкообразный аэрозольный состав, включающий полипептид, и способ его приготовления
IL208070A (en) Production of a pharmaceutical composition containing myxoma virus, a pharmaceutical composition comprising myxoma virus and its use ex-vivo
MX2009010989A (es) Composiciones farmaceuticas liofilizadas y metodos de obtener y usar las mismas.
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
ECSP12012236A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
MX2010005036A (es) Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
EP2222271A4 (en) ACTIVE FORMULATIONS BASED ON ESSENTIAL OIL OF PLANTS OF THE GENUS PROTIUM, GUATTERIA, CYPERUS AND A MIXTURE THEREOF
HK1120417A1 (en) Stable nanoparticle formulations
SE0200657D0 (sv) Novel Formulation
WO2005041922A3 (en) Composition